Javascript must be enabled to continue!
PS-C06-7: NT- PRO BNP IN ARTERIAL HYPERTENSION
View through CrossRef
Objectives of the present study were to evaluate the association of N-terminal pro-B-type natriuretic peptide to hypertension and to compare NT-pro BNP levels in groups with and without arterial hypertension.
Design and method:
The study included 253 participants with cardiovasular risk aged 35–64 years and who had no clinical symptoms of heart failure. All participants were divided into to two groups: hypertensive and normotensive. High risks for heart failure included arterial hypertension, diabetes, obesity, excessive drinking of alcohol, smoking and family history of cardiovascular disease were detected by clinical examinations. Hypertension was defined as systolic BP ≧ 140 mm Hg, diastolic BP ≧ 90 mm Hg, and/or receiving treatment with anti-hypertensive agents. The NT-pro BNP determination was performed using immunoassay analyzer which utilizes reagent strip to obtain quantitative NT- pro BNP results in plasma. The cut-off point for NT-pro BNP was 125 pg/ml. All statistical analyses were made with the SPSS version 25.0. Differences between the study groups were analyzed with the chi-square test for categorical variables. P value less than 0.05 is considered as statistically significant.
Results:
The study sample consisted of 100 men and 153 women. The mean age of participants was 51.1 ± 8.2 years. In all, 49% of participants were hypertensive.
The mean age, body mass index and abdominal circumference in hypertensive group were significantly higher than in normotensive group. Elevated NT-pro BNP levels ≧ 125 pg/ml were detected in 12.6% of participants. Increased NT- pro BNP values were detected in 21.0% subjects with hypertension and in 4.6% subjects without hypertension. The mean N-terminal pro-B-type natriuretic peptide value among patients with and without hypertension were 145.0 ± 98.0 pg/ml and 112.6 ± 59.6 pg/ml. Multivariate linear regression analysis showed that age β; = 0.240, P = 0.021 and systolic blood pressure β; = 0.256, P = 0.008 were positively correlated with NT-pro BNP levels in hypertensive group.
Conclusions:
NT-pro BNP levels were significantly increased in participants with hypertension.
The present study showed that age and systolic blood pressure were significantly positively associated with NT- pro BNP levels. In case of elevated NT- pro BNP we recommend using echocardiography
Ovid Technologies (Wolters Kluwer Health)
Title: PS-C06-7: NT- PRO BNP IN ARTERIAL HYPERTENSION
Description:
Objectives of the present study were to evaluate the association of N-terminal pro-B-type natriuretic peptide to hypertension and to compare NT-pro BNP levels in groups with and without arterial hypertension.
Design and method:
The study included 253 participants with cardiovasular risk aged 35–64 years and who had no clinical symptoms of heart failure.
All participants were divided into to two groups: hypertensive and normotensive.
High risks for heart failure included arterial hypertension, diabetes, obesity, excessive drinking of alcohol, smoking and family history of cardiovascular disease were detected by clinical examinations.
Hypertension was defined as systolic BP ≧ 140 mm Hg, diastolic BP ≧ 90 mm Hg, and/or receiving treatment with anti-hypertensive agents.
The NT-pro BNP determination was performed using immunoassay analyzer which utilizes reagent strip to obtain quantitative NT- pro BNP results in plasma.
The cut-off point for NT-pro BNP was 125 pg/ml.
All statistical analyses were made with the SPSS version 25.
Differences between the study groups were analyzed with the chi-square test for categorical variables.
P value less than 0.
05 is considered as statistically significant.
Results:
The study sample consisted of 100 men and 153 women.
The mean age of participants was 51.
1 ± 8.
2 years.
In all, 49% of participants were hypertensive.
The mean age, body mass index and abdominal circumference in hypertensive group were significantly higher than in normotensive group.
Elevated NT-pro BNP levels ≧ 125 pg/ml were detected in 12.
6% of participants.
Increased NT- pro BNP values were detected in 21.
0% subjects with hypertension and in 4.
6% subjects without hypertension.
The mean N-terminal pro-B-type natriuretic peptide value among patients with and without hypertension were 145.
0 ± 98.
0 pg/ml and 112.
6 ± 59.
6 pg/ml.
Multivariate linear regression analysis showed that age β; = 0.
240, P = 0.
021 and systolic blood pressure β; = 0.
256, P = 0.
008 were positively correlated with NT-pro BNP levels in hypertensive group.
Conclusions:
NT-pro BNP levels were significantly increased in participants with hypertension.
The present study showed that age and systolic blood pressure were significantly positively associated with NT- pro BNP levels.
In case of elevated NT- pro BNP we recommend using echocardiography.
Related Results
Theoretical Modeling of B12N12 Nanocage for the Effective Removal of Paracetamol from Drinking Water
Theoretical Modeling of B12N12 Nanocage for the Effective Removal of Paracetamol from Drinking Water
In our current investigation, we employed a B12N12 nanocage to extract paracetamol from water utilizing a DFT approach. We explored three distinct positions of paracetamol concerni...
Powerful Risk Stratification in Patients with AL Using Serum Cardiac Biomarkers.
Powerful Risk Stratification in Patients with AL Using Serum Cardiac Biomarkers.
Abstract
Introduction: We previously reported that serum cardiac biomarkers are among the most powerful predictors of overall survival. This observation was based on...
GW24-e3137 The etiology investigate of hypertension incidence in children
GW24-e3137 The etiology investigate of hypertension incidence in children
Objectives
Through retrospective analysis of related factors of children’s hypertension what is composed by primary hypertension and secondary hypertension diseas...
Outcomes in terms of Mortality in patients of Community Acquired Pneumonia with Raised B-Type Natriuretic Peptide
Outcomes in terms of Mortality in patients of Community Acquired Pneumonia with Raised B-Type Natriuretic Peptide
Background: Community-acquired pneumonia (CAP) remains a leading cause of morbidity and mortality worldwide. While B-type natriuretic peptide (BNP) is primarily recognized as a car...
Brain natriuretic peptide inhibits hypoxic pulmonary hypertension in rats
Brain natriuretic peptide inhibits hypoxic pulmonary hypertension in rats
Brain natriuretic peptide (BNP) is a pulmonary vasodilator that is elevated in the right heart and plasma of hypoxia-adapted rats. To test the hypothesis that BNP protects against ...
Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure
Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure
The purpose of this study was to clarify whether the secretions of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are pulsatile in patients with chronic heart...
B-Type Natriuretic Peptide in Organic Mitral Regurgitation
B-Type Natriuretic Peptide in Organic Mitral Regurgitation
Background—
B-type natriuretic peptide (BNP) activation observed in cardiac diseases is a predictor of poor outcome; however, in organic mitral regurgitati...
e0653 Level change of plasma BNP and the relationships to the left ventricular aneurysm formation and cardiac performance in patients with acute myocardial infarction
e0653 Level change of plasma BNP and the relationships to the left ventricular aneurysm formation and cardiac performance in patients with acute myocardial infarction
Objective
To investigate the change of brain natriuretic peptide (BNP) in plasma and the relationships with the left ventricular aneurysm (LVA) and cardiac perfor...

